These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4580271)

  • 21. [Immune evaluation in oncologic surgery].
    Youinou P; Lozach P; Clavier J; Meyen P; Tande D; Labat JP; Charles JF
    J Chir (Paris); 1984; 121(8-9):517-26. PubMed ID: 6209291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of cell-mediated immunity after oral administration of a live influenza vaccine.
    Unanov SS; Yuminova NV; Akopova II
    Acta Virol; 1982 Dec; 26(6):474-80. PubMed ID: 6132541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cellular immunity in primary hypogammaglobulinaemia: evidence for a generalised lymphocyte defect in some patients with "common" variable hypogammaglobulinaemia.
    Luquetti A; Newton CA; Webster AD
    Allergol Immunopathol (Madr); 1981; 9(4):295-306. PubMed ID: 6975557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of influenzal infection on the degree of blastic transformation of phytohemagglutinin-stimulated lymphocytes.
    Pluzańska A; Polkowska-Kulesza E; Krauze-Jaworska H; Musial W
    Pol Med J; 1972; 11(1):78-82. PubMed ID: 5041004
    [No Abstract]   [Full Text] [Related]  

  • 25. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 26. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
    Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
    Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation.
    Wu F; Wang ZB; Lu P; Xu ZL; Chen WZ; Zhu H; Jin CB
    Ultrasound Med Biol; 2004 Sep; 30(9):1217-22. PubMed ID: 15550325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-selected mimics of hepatitis C virus hypervariable region 1 activate both primary and memory Th lymphocytes.
    Frasca L; Scottà C; Del Porto P; Nicosia A; Pasquazzi C; Versace I; Masci AM; Racioppi L; Piccolella E
    Hepatology; 2003 Sep; 38(3):653-63. PubMed ID: 12939592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunological profile of patients with neoplastic disease].
    Stivala F; Catania G; Basile F; Malaponte G; Bottiglieri C; Giovinetto A
    Minerva Chir; 1981 Mar; 36(5):297-302. PubMed ID: 6972495
    [No Abstract]   [Full Text] [Related]  

  • 30. Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity.
    Oh S; Berzofsky JA; Burke DS; Waldmann TA; Perera LP
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3392-7. PubMed ID: 12626740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Changes in cellular immunity after administration of nucleotides].
    Kocián J; Kalanin J
    Cas Lek Cesk; 1999 Mar; 138(7):209-11. PubMed ID: 10510536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal chromosome changes in stimulated lymphocytes of untreated human B-cell leukemias.
    Sadamori N; Han T; Minowada J; Matsui S; Sandberg AA
    Cancer Res; 1983 Jul; 43(7):3287-91. PubMed ID: 6850637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Neopterin, a new biochemical marker for the detection of activated T lymphocytes].
    Niederwieser D; Huber C; Wachter H
    Wien Klin Wochenschr; 1983 Mar; 95(5):161-4. PubMed ID: 6602425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Basic principles of active and passive immunizations].
    Gerth HJ
    Internist (Berl); 1979 Jun; 20(6):264-72. PubMed ID: 378889
    [No Abstract]   [Full Text] [Related]  

  • 35. [Controlled study of unspecific cellular immunity in cancer patients].
    Dominioni L; Dionigi R; Prati U; Cividini F; Cincera M; Pavesi L; Della Cuna GR
    Minerva Med; 1981 Mar; 72(12):733-40. PubMed ID: 6971418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of cellular immune changes in the draining paraaortic lymph nodes in syngeneic and allogeneic pregnancies.
    Gottesman SR; Stutman O
    Prog Clin Biol Res; 1981; 70():121-36. PubMed ID: 6458821
    [No Abstract]   [Full Text] [Related]  

  • 37. [The interferon status and cellular immunity of pregnant women with viral hepatitis B].
    Akhmedova MD; Zmyzgova AV; Karimova MT
    Ter Arkh; 1995; 67(11):7-10. PubMed ID: 8571261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction and paralysis: a conceptual framework from which to examine the intestinal immune system.
    Kagnoff MF
    Gastroenterology; 1974 Jun; 66(6):1240-56. PubMed ID: 4597753
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytokine and hepatitis B virus DNA co-immunizations enhance cellular and humoral immune responses to the middle but not to the large hepatitis B virus surface antigen in mice.
    Geissler M; Schirmbeck R; Reimann J; Blum HE; Wands JR
    Hepatology; 1998 Jul; 28(1):202-10. PubMed ID: 9657113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cytogenetic disorders in the lymphoid cells and body immunoreactivity of human beings and macaques exposed to viruses].
    Il'inskikh NN; Il'inskikh IN
    Zh Obshch Biol; 1981; 42(5):732-42. PubMed ID: 6974931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.